Difference between revisions of "Haloperidol-Lurasidone"

From Psychiatrienet
Jump to: navigation, search
Line 2: Line 2:
| from = Haloperidol
| from = Haloperidol
| to = Lurasidon
| to = Lurasidon
| stop =  
| stop = {{StopStand}}
* '''Day 1-7:''' gradually reduce the dose of haloperidol to 50% of the dose.
| start = {{StartStand}}
* '''Day 8-14:''' gradually reduce the dose of haloperidol to 0% of the dose
| info =  
* '''Day 14:''' stop administration of haloperidol.
| start =  
| view = switchstandaardup en down.jpg
* '''Day 1-7:''' start administration of lurasidon in a dose of 40 mg/day.
* '''Day 8-14:''' increase the dose of lurasidon to 80 mg/day if necessary. Note: Continue the dose of lurasidone 40 mg/day if the patiënt is stable. 
| info = {{caveQT}}
* It is also possible to start administration of lurasidon on day 1 in a dose of 80 mg/day. <ref>[http://www.ncbi.nlm.nih.gov/pubmed/23473350 McEvoy JP et al. Effectiveness of lurasidone in patients with schizophrenia or schizoaffective disorder switched from other antipsychotics: a randomized, 6-week, open-label study.J Clin Psychiatry. 2013 Feb;74(2):170-9.]</ref>

Revision as of 15:28, 16 March 2015

Type Antipsychotic
Group Butyrophenones
ATC-code N05AD01
Medscape Haloperidol
PubChem 3559
PubMed Haloperidol
Drugs.com haloperidol
Kompas (Dutch) Haloperidol
Wikipedia Haloperidol
Type Antipsychotic
Group Atypical AP
Medscape Lurasidone
PubMed Lurasidone
Kompas (Dutch) Lurasidone
Wikipedia Lurasidone

Switch medication from Haloperidol to Lurasidon.

Nietinrijdenbord.png Stop Haloperidol
  • Day 1-4: approx. 75% of initial dose
  • Day 5-8: approx. 50% of initial dose
  • Day 9-12: approx. 25% of initial dose
  • Day 13: stop
Eenrichtingbord.png Start Lurasidon
  • Day 1-4: approx. 25% of target dose
  • Day 5-8: approx. 50% of target dose
  • Day 9-12: approx. 75% of target dose
  • Day 13: target dose
Infobord.png More information
  • More information on switching to lurasidon: see reference. [5]
    Switchstandaardup en down.jpg
Nietinrijdenbord.png — Haloperidol
Eenrichtingbord.png — Lurasidon

The editors of psychiatrienet.nl take the greatest care to provide up-to-date and accurate information on this site. Nevertheless, mistakes and omissions cannot be entirely excluded. No rights devolve from the information provided. The editors and other providers of information to this site accept no responsibility for the content of this site or for the information provided therein; neither do they accept responsibility for possible damages which may derive from the use of the information on this site or from the linked sites. The editorial board accepts no responsibility for the content of the (linked) sites, for access to them, or for the products and services on these sites, nor for the occurrence of errors, viruses, and/or disruptions in service.